Auxilius is the leading Clinical Trial Financial Management platform designed specifically for the needs of finance and accounting professionals in the biopharma industry. Tailored to the unique complexities of R&D, Auxilius complements existing FP&A, ERP, and clinical tools to help teams streamline processes like budgeting, forecasting, accruals, and vendor management. By providing transparency, control, and automation, Auxilius enables organizations to manage clinical trial finances more efficiently, mitigate risks, and ensure accurate financial reporting.

Auxilius Live Sessions

Join us for a live session with experts from from Crowe and Auxilius, covering strategies for managing risks, improving transparency, and ensuring accurate accruals for clinical trial costs.

Topics include:

*   Industry trends and the SEC regulatory climate around clinical trial accounting – Takeaways from 2024 year end report
*   Issues that drive audit matters, regulatory risk, and operational efficiency in clinical trial finance
*   Common challenges in accrual estimation, including vendor estimate reliance and investigator spend accuracy
*   Best practices for internal controls and a SOX compliant end-to-end workflow


Risk Mitigation and Reporting Readiness in Clinical Trial Accounting

*ClinOps doubling your trial size and not sure how it impacts your capital needs?*

*Trial enrollment not following initial projections?*

*Unsure how the latest change order will impact your runway?*

Join us for a live session all about automating budget forecasting using clinical drivers! Designed for FP\&A professionals in biopharma, this session illustrates how to integrate key clinical drivers into financial forecasting models for more effective capital planning. You'll discover practical strategies to transform complex clinical data into actionable insights that drive smarter budgeting decisions.

Featuring industry perspective from Robbie Tantoco, a strategic financial leader in the life sciences industry, the session will close with a live walkthrough of how biopharma customers automate clinical forecasts using Auxilius' integrated platform.

Don't miss this opportunity to refine your budgeting strategy and empower your financial planning!

 

Topics include:

*   Best practices in using clinical drivers for trial forecasts
*   Ways to link clinical metrics to financial strategy, informing capital allocation and project prioritization
*   How leading biopharma companies automate forecasts with Auxilius


Using Clinical Drivers In Budget Forecasts and Strategic Planning

As clinical-stage biotech companies look ahead to 2025, understanding the latest accounting, audit, and reporting challenges is essential for staying compliant and making informed financial decisions.

During this session Auxilius and Deloitte will cover key accounting and reporting updates that are critical to clinical-stage life science companies, while providing practical strategies for R\&D accruals and trial financial planning.

Topics Covered Include:

• Accounting & Reporting Update, including Segment Reporting ASU

• SEC Comment Letter Trends

• Critical Audit Matter Trends

• Public versus Private Company Considerations

• R\&D and Clinical Accrual Considerations

• Strategies to Address Challenging Accrual Scenarios: Investigator Spend

This webinar is designed for finance and accounting professionals in the biotech sector looking to stay ahead of regulatory changes and improve their financial processes.


Deloitte + Auxilius: Accounting & Finance for Clinical Stage Companies

Looking to brush up on CMC accounting processes and methodologies? Join our live session to dive into all things CMC accounting!

In this session we will cover:

\- Current approaches to managing volume and complexity of CMC vendors, contracts, and change orders

\- Challenges with CMC accruals

\- GL structure

\- Opportunities for automation


Challenges and Opportunities in Managing CMC Accounting

Still unsure what R\&D accrual methodology you should use for your clinical trial?

Come join PMV Pharmaceuticals (PMVP) CFO, Michael Carulli and Auxilius President and COO, Erin Warner Guill as they discuss how to evaluate and evolve different R\&D accrual methodologies.

They will then discuss how PMV weighed and evolved its methodologies over time on the Auxilius platform.

Specific topics discussed:

*   The benefits and drawbacks of different accrual methodologies
*   How PMV Pharma decided which accrual methodology to use
*   How PMV Pharma evolved its accrual methodology over time
*   How the Auxilius platform supports a wide array of accrual methodologies


Determining the Best Expense Source in Accrual Preparation (With PMV Pharma)

Speakers

Mike Carulli

CFO, PMV Pharmaceuticals

Erin Warner Guill

President & COO, Auxilius

Replays

Risk Mitigation and Reporting Readiness in Clinical Trial Accounting

Using Clinical Drivers In Budget Forecasts and Strategic Planning